Article
Inhibition of mammary carcinoma cell growth by RXR is mediated by the receptor's oligomeric switch.
Journal of molecular biology - 16 Apr 2010
Yasmin Rubina, Kannan-Thulasiraman Padmamalini, Kagechika Hiroyuki, Dawson Marcia I, Noy Noa
Abstract excerpt
Ligands that activate the nuclear receptor retinoid X receptor (RXR) display potent anticarcinogenic activities, but the mechanisms by which these compounds inhibit carcinoma cell growth are poorly understood. While RXR can regulate gene expression due to its intrinsic ligand-activated transcription function, this receptor can also regulate transcription by functioning as a ligand-controlled DNA architectural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
